A study for relationship between the trough concentration of linezolid and neurotoxicity.

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900026662

Enrollment

Unknown

Registered

2019-10-17

Start date

2019-11-01

Completion date

Unknown

Last updated

2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multi-drug resistant tuberculosis

Interventions

Experiment group:therapeutic drug monitoring

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients who take linezolid >6 months for their MDR-TB.

Exclusion criteria

Exclusion criteria: no exclusion criteria.

Design outcomes

Primary

Measure	Time frame
Trough concentration of linezolid;neuropathy;	—

Countries

China

Contacts

Public ContactPeize Zhang

The Third People's Hospital of Shenzhen

Peizezhang@aliyun.com+86 13509650204

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026